EXEL - EXELIXIS, INC.


41.28
-0.410   -0.993%

Share volume: 3,438,511
Last Updated: 03-05-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: -0.04%

PREVIOUS CLOSE
CHG
CHG%

$41.69
-0.41
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-29-2024 06-28-2024 09-27-2024 01-03-2025 04-04-2025 07-04-2025 10-03-2025 01-02-2026
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 04-30-2024 08-06-2024 10-29-2024 02-11-2025 05-13-2025 07-28-2025 11-04-2025 02-10-2026
Cash flow financing -184.048 M -262.422 M 5.696 M -188.034 M -294.823 M -316.343 M -103.860 M -254.568 M
Other financing cash flows 0.000 -13.026 M -2.166 M -16.445 M -22.516 M -40.502 M -3.377 M -4.825 M
Cash flow 68.822 M -61.102 M 59.887 M -40.972 M -33.622 M -19.319 M 211.867 M 106.188 M
Net income 37.317 M 226.116 M 117.973 M 139.861 M 159.616 M 184.848 M 193.578 M 244.528 M
Depreciation 6.378 M 7.329 M 7.454 M 7.642 M 7.345 M 7.342 M 7.422 M 6.946 M
Changes in inventories 21.106 M 0.000 0.000 0.000 71.000 K 0.000 0.000 0.000
Changes in receivables 240.577 M 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Investing Cashflow 111.793 M 81.772 M -217.147 M -93.201 M 49.764 M 248.031 M 25.405 M 27.241 M
Net Borrowings -1.031 B 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Investing Activity Other 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Dividends Paid 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Exchange Rate Effect 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Capital Expenditures -9.691 M 6.570 M 8.197 M 3.977 M 2.952 M 2.838 M 1.482 M 1.157 M
Cash Change 963.256 M -61.102 M 59.887 M -40.972 M -33.622 M -19.319 M 211.867 M 106.188 M